div class=trans-pagebuttonPage 1button div class=trans-image amp-img class=trans-thumb alt=Page 1: · worldwide In June 2018 Biocon and Mylan became the first to receive approval for biosimilar Pegfilgrastim from the US FDA ahead of a pack of strong competitors who are also src=https:reader035fdocumentsusreader035viewer20220708015f028dcd7e708231d404d6c8html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 2button div class=trans-image amp-img class=trans-thumb alt=Page 2: · worldwide In June 2018 Biocon and Mylan became the first to receive approval for biosimilar Pegfilgrastim from the US FDA ahead of a pack of strong competitors who are also src=https:reader035fdocumentsusreader035viewer20220708015f028dcd7e708231d404d6c8html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 3button div class=trans-image amp-img class=trans-thumb alt=Page 3: · worldwide In June 2018 Biocon and Mylan became the first to receive approval for biosimilar Pegfilgrastim from the US FDA ahead of a pack of strong competitors who are also src=https:reader035fdocumentsusreader035viewer20220708015f028dcd7e708231d404d6c8html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 4button div class=trans-image amp-img class=trans-thumb alt=Page 4: · worldwide In June 2018 Biocon and Mylan became the first to receive approval for biosimilar Pegfilgrastim from the US FDA ahead of a pack of strong competitors who are also src=https:reader035fdocumentsusreader035viewer20220708015f028dcd7e708231d404d6c8html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 5button div class=trans-image amp-img class=trans-thumb alt=Page 5: · worldwide In June 2018 Biocon and Mylan became the first to receive approval for biosimilar Pegfilgrastim from the US FDA ahead of a pack of strong competitors who are also...